Race Oncology Limited

ASX:RAC 株式レポート

時価総額:AU$243.8m

Race Oncology マネジメント

マネジメント 基準チェック /14

Race Oncologyの CEO はDaniel Tillettで、 Nov2023年に任命され、 の在任期間は 1 年未満です。 の年間総報酬はA$ 1.12Mで、 13%給与と87%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の10.13%を直接所有しており、その価値はA$ 24.69M 。経営陣と取締役会の平均在任期間はそれぞれ0.9年と2年です。

主要情報

Daniel Tillett

最高経営責任者

AU$1.1m

報酬総額

CEO給与比率13.0%
CEO在任期間less than a year
CEOの所有権10.1%
経営陣の平均在職期間less than a year
取締役会の平均在任期間2yrs

経営陣の近況

Recent updates

Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

Aug 26
Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

Jun 20
Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Feb 17
We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

CEO報酬分析

Race Oncology の収益と比較して、Daniel Tillett の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024AU$1mAU$145k

-AU$14m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$11m

Jun 30 2023AU$836kAU$332k

-AU$10m

Mar 31 2023n/an/a

-AU$10m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$11m

Jun 30 2022AU$1mAU$228k

-AU$11m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$9m

Sep 30 2021n/an/a

-AU$8m

Jun 30 2021AU$1mAU$167k

-AU$6m

Mar 31 2021n/an/a

-AU$5m

Dec 31 2020n/an/a

-AU$4m

Sep 30 2020n/an/a

-AU$4m

Jun 30 2020AU$147kn/a

-AU$4m

報酬と市場: Danielの 総報酬 ($USD 728.87K ) は、 Australian市場 ($USD 688.70K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Danielの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Daniel Tillett

less than a year

在職期間

AU$1,118,157

報酬

Dr. Daniel Tillett is Non-Executive Director of Tryptamine Therapeutics Limited from November 8, 2024. Dr. Tillett joined the Tryptamine Therapeutics Limited on November 8, 2024. Dr. Tillett has been Chief...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Peter Smith
Executive Chairman1.4yrsAU$327.72kデータなし
Daniel Tillett
CEO, Managing Director & Directorless than a yearAU$1.12m10.13%
A$ 24.7m
Michelle Rashford
Chief Medical Officer1.3yrsAU$704.81kデータなし
Brendan Brown
Chief Financial Officerless than a yearデータなしデータなし
Sophia Moscovis
Vice President of Operations & Strategyless than a yearデータなしデータなし
Peter Webse
Company Secretary8.5yrsデータなしデータなし

0.9yrs

平均在職期間

経験豊富な経営陣: RACの経営陣は 経験豊富 とはみなされません ( 0.9年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Peter Smith
Executive Chairman1.4yrsAU$327.72kデータなし
Daniel Tillett
CEO, Managing Director & Directorless than a yearAU$1.12m10.13%
A$ 24.7m
Martin Tallman
Member of Scientific Advisory Board7.9yrsデータなしデータなし
Douglas Smith
Member of Scientific Advisory Boardno dataデータなしデータなし
Roland Walter
Member of Scientific Advisory Boardno dataデータなしデータなし
Borje Andersson
Chairman of Clinical Advisory Board4.9yrsAU$815.36kデータなし
Jaap-Jan Boelens
Member of Clinical Advisory Board4.8yrsデータなしデータなし
Jianjun Chen
Member of Scientific Advisory Board3.6yrsデータなしデータなし
James Breitenbucher
Member of Scientific Advisory Board2.5yrsデータなしデータなし
Daniel Hoff
Clinical Advisory Boardless than a yearデータなしデータなし
Erin Howden
Member of Scientific Advisory Boardless than a yearデータなしデータなし
Serge Scrofani
Independent Non-Executive Directorless than a yearデータなしデータなし

2.0yrs

平均在職期間

経験豊富なボード: RACの 取締役会経験豊富 ではない ( 2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。